Synthetic Biologics Inc. (SYN) News Nov 14, 2014, 3:59

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Synthetic Biologics Inc. (SYN) News Nov 14, 2014, 3:59 p.m.
MarketWatch News on SYN
Wednesday’s biggest gaining & declining stocks 4:46 p.m. Nov. 30, 2011 - Kate Gibson
Adeona Pharmaceuticals shares down 9% 9:42 a.m. Dec. 29, 2010 - Nick Godt
Wednesday's biggest gaining and declining stocks 4:20 p.m. April 14, 2010 - MarketWatch
Adeona soars; Molecular Insight retreats. 3:13 p.m. April 14, 2010 - Val Brickates Kennedy
Adeona in spotlight; indices sluggish 8:56 a.m. April 14, 2010 - Val Brickates Kennedy
Advertisement
Other News on SYN
Synthetic Biologics' (SYN) CEO Jeff Riley on Q3 2014 Results - Earnings Call Transcript 2:14 p.m. Nov. 14, 2014 - Seeking Alpha
10-Q: SYNTHETIC BIOLOGICS, INC. 10:05 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics 7:54 a.m. Oct. 10, 2014 - Seeking Alpha
Forward Pharma on deck for IPO 7:33 a.m. Oct. 7, 2014 - Seeking Alpha
Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog 4:00 p.m. Sept. 16, 2014 - Zacks.com
Synthetic Biologics (SYN) Looks Strong: Stock Gains 13.9% - Tale of the Tape 7:44 a.m. Sept. 2, 2014 - Zacks.com
Synthetic Biologics (SYN) Jumps: Stock Adds 16% in Session - Tale of the Tape 7:51 a.m. Aug. 21, 2014 - Zacks.com
Synthetic Biologics' (SYN) CEO Jeff Riley on Q2 2014 Results - Earnings Call Transcript 1:30 p.m. Aug. 14, 2014 - Seeking Alpha
10-Q: SYNTHETIC BIOLOGICS, INC. 1:23 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Synthetic Biologics Inc. (SYN) Looks Strong as Stock Gains 34.3% - Tale of the Tape 7:44 a.m. July 30, 2014 - Zacks.com
Synthetic Bio up big on no news 1:04 p.m. July 29, 2014 - Seeking Alpha
Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio 10:33 a.m. July 10, 2014 - Seeking Alpha
Why I'm Short Synthetic Biologics After Phase II Relapsing-Remitting MS Data 4:53 p.m. May 19, 2014 - Seeking Alpha
Why Synthetic Biologics (SYN) Stock Is Surging Today 11:50 a.m. May 15, 2014 - TheStreet.com
Synthetic Biologics' (SYN) CEO, Jeff Riley on Q1 2014 Results - Earnings Call Transcript 11:18 a.m. May 15, 2014 - Seeking Alpha
More on Synthetic Biologics Q1 results 9:48 a.m. May 15, 2014 - Seeking Alpha
Synovus sets 1:7 reverse stock split 7:34 a.m. April 25, 2014 - Seeking Alpha
AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore 8:49 a.m. April 11, 2014 - Seeking Alpha
Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster? 10:06 a.m. April 10, 2014 - Seeking Alpha
10-K: SYNTHETIC BIOLOGICS, INC. 3:52 p.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Loading more headlines...
Press Releases on SYN
Synthetic Biologics Reports Third Quarter 2014 Financial Results and Operational Highlights 6:56 a.m. Nov. 14, 2014 - PR Newswire - PRF
Synthetic Biologics to Report Third Quarter 2014 Financial Results 6:57 a.m. Nov. 6, 2014 - PR Newswire - PRF
Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 7:40 a.m. Oct. 30, 2014 - PR Newswire - PRF
Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 5:57 a.m. Oct. 22, 2014 - PR Newswire - PRF
Synthetic Biologics to Raise $20.7 Million in Registered Direct Offering 7:55 a.m. Oct. 10, 2014 - PR Newswire - PRF
Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 9:35 a.m. Sept. 16, 2014 - PR Newswire - PRF
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 12:23 p.m. Sept. 12, 2014 - PR Newswire - PRF
Synthetic Biologics to Host Phase II Trimesta™ for Multiple Sclerosis Conference Call 5:58 a.m. Sept. 11, 2014 - PR Newswire - PRF
Synthetic Biologics to Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor Day 11:04 a.m. Sept. 10, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Synthetic Biologics Highlights SYN-005 Data Presented at the 54th ICAAC from Novel Whooping Cough (Pertussis) Program 5:58 a.m. Sept. 8, 2014 - PR Newswire - PRF
Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC 7:58 a.m. Sept. 7, 2014 - PR Newswire - PRF
Synthetic Biologics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City 5:58 a.m. Sept. 3, 2014 - PR Newswire - PRF
Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 6:33 a.m. Sept. 2, 2014 - PR Newswire - PRF
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5:56 a.m. Aug. 28, 2014 - PR Newswire - PRF
Synthetic Biologics Announces Presentation of Poster for SYN-004 C. difficile Program at IDWeek 2014™ 5:58 a.m. Aug. 26, 2014 - PR Newswire - PRF
Synthetic Biologics to Host Irritable Bowel Syndrome (IBS) Investor Day 5:56 a.m. Aug. 13, 2014 - PR Newswire - PRF
Synthetic Biologics to Report Second Quarter 2014 Financial Results 5:56 a.m. Aug. 7, 2014 - PR Newswire - PRF
Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile 5:58 a.m. Aug. 5, 2014 - PR Newswire - PRF
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 7:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Independents Finally Center Stage on Election Night

Updated Category News Views 36

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

Continue Reading
HIMS Lawsuit: Investors Under the Gun Before Deadline

Updated Category News Views 46

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 96

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
111, Inc. Strategizes with Advisors Amid Proposal Talks

Updated Category News Views 112

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Continue Reading
American Water's $10K Grant Boosts Student Financial Skills

Updated Category News Views 0

Financial Literacy: Building Skills for the Future When it comes to prepping kids for the real world, it's not just about packing their backpacks with textbooks and pencils; it's about arming them with the know-how to make smart financial moves. American Water Charitable Foundation's recent $10,000 grant to Junior Achievement of the Heartland is a shining example of the...

Continue Reading
Metallium's U.S. Supply Chain Ambitions Hinge on Traxys MOU

Updated Category News Views 111

Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...

Continue Reading
Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Updated Category News Views 64

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Continue Reading
Mesirow Expands Retirement Reach with flexPATH Deal

Updated Category News Views 126

Retirement Industry Shake-Up Here's the scoop: Mesirow's swinging big in the retirement scene with its latest acquisition of flexPATH's plan-level 3(38) business. In the world of outsourced fiduciarity—for thems ain't in the know—that's like bolting a turbocharger to an already darn good engine. Mesirow might just be strapping itself in for a wild ride in this 2026...

Continue Reading
Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 135

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
Sinopec's Catalyst Conference: Driving Global Innovation

Updated Category News Views 90

The Role of Catalysts in Modern Industry Swing by any bustling industrial hub, and you're likely to catch talk about catalysts—unsung heroes that make the machinery of modern industry run smoother, faster, and cleaner. Over in Tianjin, China, Sinopec just wrapped up its Second International Catalyst Customer Conference, which is less of a tongue-twister than it sounds....

Continue Reading

Top 5 Most Recently Viewed Articles

Rezolve Ai Achieves Major Growth with Russell Index Inclusion

Updated Category News Views 322

Rezolve Ai Celebrates Inclusion in Prestigious Russell Indices Rezolve Ai (NASDAQ: RZLV) has reached a significant milestone in its journey by being added to the Russell 2000 and Russell 3000 indices. This achievement comes as a result of an immensely successful year, with the company's annual recurring revenue (ARR) soaring to $70 million, showcasing its rapid growth...

Continue Reading
VitalHub Demonstrates Growth with Strong 2024 Financials

Updated Category News Views 369

VitalHub Reports Impressive Financial Growth VitalHub Corp, a prominent software provider in health and human services, recently reported robust financial results for 2024. The company disclosed significant advancements in their Annual Recurring Revenue (ARR), which surged 59% year over year, reaching $71.1 million. Additionally, the total revenue increased by a...

Continue Reading
Artius II Acquisition Inc. Launches $200 Million IPO on Nasdaq

Updated Category News Views 229

Artius II Acquisition Inc. Launches Its Initial Public Offering In an exciting development for investors and the market, Artius II Acquisition Inc. has unveiled its initial public offering (IPO) priced at an impressive $200 million. This marks a significant moment for the company as it takes steps to expand its reach in the investment landscape. Understanding the IPO...

Continue Reading
Surge in Foreign Capital Sparks Japanese Stock Market Growth

Updated Category News Views 85

Foreign Investment Surge in Japanese Stocks Recent trends indicate a remarkable increase in foreign investments in Japanese stocks, particularly noted in the week ending October 5. Following comments from Prime Minister Shigeru Ishiba regarding monetary policy, the yen experienced a depreciation, enhancing the appeal of Japanese exporters to foreign buyers. Significant...

Continue Reading
Jason Maynard Takes the Helm as CEO of Qualtrics

Updated Category News Views 194

Qualtrics Welcomes Jason Maynard as New CEO Qualtrics, a pioneer in experience management, has recently appointed Jason Maynard as its Chief Executive Officer. Maynard, who will also take a seat on the Qualtrics Board of Directors, officially steps into this influential role today. A Leader with Proven Experience With an impressive background of 30 years in the technology...

Continue Reading